Prehosp Emerg Care. 2021 Mar-Apr;25(2):268-273. doi: 10.1080/10903127.2020.1737280. Epub 2020 Mar 20.
Vasopressor medications are frequently used in the management of hypotension secondary to shock. However, little data exists regarding their use in hypotensive trauma patients and their use is controversial.
The Department of Defense Trauma Registry was queried from January 2007 to August 2016 using a series of procedural codes to identify eligible casualties, which has been previously described. Mortality was compared between hypotensive casualties with documentation of receipt of vasopressor medications versus casualties not receiving vasopressors. To control for potential confounders, comparisons were repeated by constructing a multivariable logistic regression model that utilized patient category, mechanism of injury, composite injury severity score, total blood products transfused, prehospital heart rate and prehospital systolic pressure. Survival was compared between these groups using propensity matching.
Our search strategy yielded 28,222 patients, 124 (0.4%) of whom received prehospital vasopressors. On univariable analysis vasopressor use was associated with lower odds of survival (OR 0.09, 0.06-0.13). The lower odds of survival persisted in the multivariate logistic regression model (OR 0.32, 0.18-0.56). Survival was lower among the vasopressor group (71.3%) when compared to a propensity matched cohort (94.3%).
In this dataset, prehospital vasopressor use was associated with lower odds of survival. This finding persisted when adjusting for confounders and in a propensity matched cohort model.
血管加压药物经常用于治疗休克引起的低血压。然而,关于其在低血压创伤患者中的使用的数据很少,其使用存在争议。
使用一系列程序代码,从 2007 年 1 月到 2016 年 8 月,对国防部创伤登记处进行了查询,以确定合格的伤员,这一点已在前文描述过。比较有低血压记录并接受血管加压药物治疗的伤员与未接受血管加压药物治疗的伤员的死亡率。为了控制潜在的混杂因素,通过构建多变量逻辑回归模型来重复比较,该模型使用患者类别、损伤机制、复合损伤严重程度评分、总输血量、院前心率和院前收缩压。使用倾向匹配比较这些组之间的生存情况。
我们的搜索策略产生了 28222 名患者,其中 124 名(0.4%)接受了院前血管加压药物治疗。在单变量分析中,血管加压药物的使用与较低的生存几率相关(OR 0.09,0.06-0.13)。在多变量逻辑回归模型中,这种较低的生存几率仍然存在(OR 0.32,0.18-0.56)。与倾向匹配队列(94.3%)相比,血管加压剂组的生存率较低(71.3%)。
在本数据集,院前使用血管加压药物与较低的生存几率相关。当调整混杂因素和倾向匹配队列模型时,这一发现仍然存在。